SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
NeurAxis, Inc. (NRXS) has a negative trailing P/E of -8.2, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 18.9 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -12.25%, forward earnings yield 5.29%.
Criteria proven by this page:
- VALUE (83/100, Pass) — analyst target implies upside (+14.3%).
- Forward P/E 18.9 — analysts expect a return to profitability with estimated EPS of $0.37 for FY2028.
- Trailing Earnings Yield -12.25% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 5.29% as earnings recover.
- Analyst consensus target $8.00 (+14.3% upside) — modest upside expected.
Overall SharesGrow Score: 48/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
83/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NRXS
Valuation Multiples
P/E (TTM)-8.2
Forward P/E18.9
PEG RatioN/A
Forward PEGN/A
P/B Ratio18.73
P/S Ratio21.97
EV/EBITDA-9.6
Per Share Data
EPS (TTM)$-0.86
Forward EPS (Est.)$0.37
Book Value / Share$0.37
Revenue / Share$0.39
FCF / Share$-0.71
Yields & Fair Value
Earnings Yield-12.25%
Forward Earnings Yield5.29%
Dividend Yield0.00%
Analyst Target$8.00 (+14.3%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2020 |
-8.7 |
0.00 |
19.65 |
16.73 |
- |
| 2021 |
-10.7 |
0.47 |
-39.11 |
11.87 |
- |
| 2022 |
-10.6 |
1.31 |
-9.06 |
18.80 |
- |
| 2023 |
-1.1 |
0.00 |
-11.98 |
6.83 |
- |
| 2024 |
-2.0 |
0.04 |
7.86 |
6.05 |
- |
| 2025 |
-5.3 |
0.24 |
12.13 |
11.55 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2020 |
$-0.75 |
$1.93M |
$-4.05M |
-209.8% |
| 2021 |
$-0.57 |
$2.72M |
$-3.07M |
-112.9% |
| 2022 |
$-0.78 |
$2.68M |
$-4.78M |
-178% |
| 2023 |
$-4.03 |
$2.46M |
$-14.63M |
-594.6% |
| 2024 |
$-1.16 |
$2.69M |
$-8.24M |
-306.8% |
| 2025 |
$-0.95 |
$3.57M |
$-7.8M |
-218.5% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$-0.54 |
$-0.66 – $-0.42 |
$9.55M |
$9M – $10.1M |
2 |
| 2027 |
$-0.02 |
$-0.02 – $-0.02 |
$20.6M |
$20.22M – $20.98M |
1 |
| 2028 |
$0.37 |
$0.36 – $0.38 |
$32.7M |
$32.1M – $33.3M |
1 |
